Insulin lispro is a rapid-acting insulin analog used to improve glycemic control in patients with type 1 and type 2 diabetes mellitus. As a modified form of human insulin, it functions by mimicking the… Read more
Insulin lispro is a rapid-acting insulin analog used to improve glycemic control in patients with type 1 and type 2 diabetes mellitus. As a modified form of human insulin, it functions by mimicking the body’s natural insulin response to promote glucose uptake and suppress hepatic glucose production. Laboratories supporting the development and quality control of this therapeutic protein rely on specialized compounds for precise analytical testing. This category includes high-quality reference standards essential for verifying potency and identity in regulatory assays. It also features a selection of pharmacopeial and non-pharmacopeial impurities, including degradation products, which are critical for rigorous impurity profiling and method validation. Additionally, stable isotope-labeled compounds are available to assist in quantitative analysis, such as LC-MS/MS, where they serve as internal standards to correct for matrix effects and ensure accurate measurement of drug concentrations throughout the manufacturing and stability testing lifecycle.